Advances in saponin-based adjuvants.

Area of Science:

• Immunology
• Natural Product Chemistry
• Pharmacology

Background:

• Saponins, natural glycosides, possess diverse biological activities.
• They can activate the mammalian immune system, making them potential vaccine adjuvants.
• Quil A and QS-21 from Quillaja saponaria are established saponin adjuvants, effective for Th1 and CTL responses.

Purpose of the Study:

• To review current advancements in saponin-based vaccine adjuvants.
• To discuss the structure-activity relationships of saponin adjuvants.
• To highlight the potential of various natural product-derived saponins as vaccine adjuvants.

Main Methods:

• Literature review of studies on saponin adjuvant effects.
• Analysis of structure-activity relationships based on recent findings.
• Summary of research on alternative saponin sources.

Main Results:

• Quillaja saponins (Quil A, QS-21) stimulate Th1 and CTL responses, beneficial for subunit and cancer vaccines.
• Quillaja saponins exhibit significant toxicity, hemolytic effects, and instability, limiting their application.
• Research is actively exploring other natural products for novel saponin adjuvants.

Conclusions:

• Saponins hold significant potential as vaccine adjuvants due to their immunomodulatory properties.
• Overcoming the limitations of current saponin adjuvants is crucial for broader vaccine development.
• Further research into diverse saponin structures may yield safer and more effective adjuvant candidates.